HEADER MEMBRANE PROTEIN 19-SEP-23 8WFL TITLE HUMAN GLYCINE TRANSPORTER 1 IN COMPLEX WITH PF-03463275 IN OUTWARD TITLE 2 FACING CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM- AND CHLORIDE-DEPENDENT GLYCINE TRANSPORTER 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GLYT-1,GLYT1,SOLUTE CARRIER FAMILY 6 MEMBER 9; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A9; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: HEK293F KEYWDS GLYT1, PF03463275, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.WEI,Y.ZHAO REVDAT 4 25-JUN-25 8WFL 1 REMARK REVDAT 3 23-OCT-24 8WFL 1 REMARK REVDAT 2 17-APR-24 8WFL 1 JRNL REVDAT 1 03-APR-24 8WFL 0 JRNL AUTH Y.WEI,R.LI,Y.MENG,T.HU,J.ZHAO,Y.GAO,Q.BAI,N.LI,Y.ZHAO JRNL TITL TRANSPORT MECHANISM AND PHARMACOLOGY OF THE HUMAN GLYT1. JRNL REF CELL V. 187 1719 2024 JRNL REFN ISSN 1097-4172 JRNL PMID 38513663 JRNL DOI 10.1016/J.CELL.2024.02.026 REMARK 2 REMARK 2 RESOLUTION. 3.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.030 REMARK 3 NUMBER OF PARTICLES : 53950 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8WFL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1300040888. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN GLYCINE TRANSPORTER 1 REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2200.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 GLY A 4 REMARK 465 ASP A 5 REMARK 465 THR A 6 REMARK 465 ARG A 7 REMARK 465 ALA A 8 REMARK 465 ALA A 9 REMARK 465 ILE A 10 REMARK 465 ALA A 11 REMARK 465 ARG A 12 REMARK 465 PRO A 13 REMARK 465 ARG A 14 REMARK 465 MET A 15 REMARK 465 ALA A 16 REMARK 465 ALA A 17 REMARK 465 ALA A 18 REMARK 465 HIS A 19 REMARK 465 GLY A 20 REMARK 465 PRO A 21 REMARK 465 VAL A 22 REMARK 465 ALA A 23 REMARK 465 PRO A 24 REMARK 465 SER A 25 REMARK 465 SER A 26 REMARK 465 PRO A 27 REMARK 465 GLU A 28 REMARK 465 GLN A 29 REMARK 465 ASN A 30 REMARK 465 GLY A 31 REMARK 465 ALA A 32 REMARK 465 VAL A 33 REMARK 465 PRO A 34 REMARK 465 SER A 35 REMARK 465 GLU A 36 REMARK 465 ALA A 37 REMARK 465 THR A 38 REMARK 465 LYS A 39 REMARK 465 ARG A 40 REMARK 465 ASP A 41 REMARK 465 GLN A 42 REMARK 465 ASN A 43 REMARK 465 ASN A 183 REMARK 465 LEU A 184 REMARK 465 THR A 185 REMARK 465 ASN A 186 REMARK 465 GLY A 187 REMARK 465 SER A 188 REMARK 465 ARG A 189 REMARK 465 PRO A 190 REMARK 465 ALA A 191 REMARK 465 ALA A 192 REMARK 465 LEU A 193 REMARK 465 PRO A 194 REMARK 465 SER A 195 REMARK 465 ASN A 196 REMARK 465 LEU A 197 REMARK 465 SER A 198 REMARK 465 HIS A 199 REMARK 465 LEU A 200 REMARK 465 LEU A 201 REMARK 465 THR A 615 REMARK 465 ILE A 616 REMARK 465 ALA A 617 REMARK 465 PRO A 618 REMARK 465 SER A 619 REMARK 465 PRO A 620 REMARK 465 GLU A 621 REMARK 465 ASP A 622 REMARK 465 GLY A 623 REMARK 465 PHE A 624 REMARK 465 GLU A 625 REMARK 465 VAL A 626 REMARK 465 GLN A 627 REMARK 465 PRO A 628 REMARK 465 LEU A 629 REMARK 465 HIS A 630 REMARK 465 PRO A 631 REMARK 465 ASP A 632 REMARK 465 LYS A 633 REMARK 465 ALA A 634 REMARK 465 GLN A 635 REMARK 465 ILE A 636 REMARK 465 PRO A 637 REMARK 465 ILE A 638 REMARK 465 VAL A 639 REMARK 465 GLY A 640 REMARK 465 SER A 641 REMARK 465 ASN A 642 REMARK 465 GLY A 643 REMARK 465 SER A 644 REMARK 465 SER A 645 REMARK 465 ARG A 646 REMARK 465 LEU A 647 REMARK 465 GLN A 648 REMARK 465 ASP A 649 REMARK 465 SER A 650 REMARK 465 ARG A 651 REMARK 465 ILE A 652 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 122 45.55 -76.43 REMARK 500 THR A 172 -169.40 -127.52 REMARK 500 ASP A 174 40.46 -107.44 REMARK 500 LEU A 205 -57.95 -122.98 REMARK 500 GLN A 206 30.78 -141.82 REMARK 500 TRP A 322 20.54 -140.37 REMARK 500 PRO A 401 41.74 -77.43 REMARK 500 GLU A 606 13.48 53.64 REMARK 500 ALA A 613 74.08 43.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-37495 RELATED DB: EMDB REMARK 900 HUMAN GLYCINE TRANSPORTER 1 IN COMPLEX WITH PF-03463275 IN OUTWARD REMARK 900 FACING CONFORMATION DBREF 8WFL A 1 652 UNP P48067 SC6A9_HUMAN 1 652 SEQRES 1 A 652 MET SER GLY GLY ASP THR ARG ALA ALA ILE ALA ARG PRO SEQRES 2 A 652 ARG MET ALA ALA ALA HIS GLY PRO VAL ALA PRO SER SER SEQRES 3 A 652 PRO GLU GLN ASN GLY ALA VAL PRO SER GLU ALA THR LYS SEQRES 4 A 652 ARG ASP GLN ASN LEU LYS ARG GLY ASN TRP GLY ASN GLN SEQRES 5 A 652 ILE GLU PHE VAL LEU THR SER VAL GLY TYR ALA VAL GLY SEQRES 6 A 652 LEU GLY ASN VAL TRP ARG PHE PRO TYR LEU CYS TYR ARG SEQRES 7 A 652 ASN GLY GLY GLY ALA PHE MET PHE PRO TYR PHE ILE MET SEQRES 8 A 652 LEU ILE PHE CYS GLY ILE PRO LEU PHE PHE MET GLU LEU SEQRES 9 A 652 SER PHE GLY GLN PHE ALA SER GLN GLY CYS LEU GLY VAL SEQRES 10 A 652 TRP ARG ILE SER PRO MET PHE LYS GLY VAL GLY TYR GLY SEQRES 11 A 652 MET MET VAL VAL SER THR TYR ILE GLY ILE TYR TYR ASN SEQRES 12 A 652 VAL VAL ILE CYS ILE ALA PHE TYR TYR PHE PHE SER SER SEQRES 13 A 652 MET THR HIS VAL LEU PRO TRP ALA TYR CYS ASN ASN PRO SEQRES 14 A 652 TRP ASN THR HIS ASP CYS ALA GLY VAL LEU ASP ALA SER SEQRES 15 A 652 ASN LEU THR ASN GLY SER ARG PRO ALA ALA LEU PRO SER SEQRES 16 A 652 ASN LEU SER HIS LEU LEU ASN HIS SER LEU GLN ARG THR SEQRES 17 A 652 SER PRO SER GLU GLU TYR TRP ARG LEU TYR VAL LEU LYS SEQRES 18 A 652 LEU SER ASP ASP ILE GLY ASN PHE GLY GLU VAL ARG LEU SEQRES 19 A 652 PRO LEU LEU GLY CYS LEU GLY VAL SER TRP LEU VAL VAL SEQRES 20 A 652 PHE LEU CYS LEU ILE ARG GLY VAL LYS SER SER GLY LYS SEQRES 21 A 652 VAL VAL TYR PHE THR ALA THR PHE PRO TYR VAL VAL LEU SEQRES 22 A 652 THR ILE LEU PHE VAL ARG GLY VAL THR LEU GLU GLY ALA SEQRES 23 A 652 PHE ASP GLY ILE MET TYR TYR LEU THR PRO GLN TRP ASP SEQRES 24 A 652 LYS ILE LEU GLU ALA LYS VAL TRP GLY ASP ALA ALA SER SEQRES 25 A 652 GLN ILE PHE TYR SER LEU GLY CYS ALA TRP GLY GLY LEU SEQRES 26 A 652 ILE THR MET ALA SER TYR ASN LYS PHE HIS ASN ASN CYS SEQRES 27 A 652 TYR ARG ASP SER VAL ILE ILE SER ILE THR ASN CYS ALA SEQRES 28 A 652 THR SER VAL TYR ALA GLY PHE VAL ILE PHE SER ILE LEU SEQRES 29 A 652 GLY PHE MET ALA ASN HIS LEU GLY VAL ASP VAL SER ARG SEQRES 30 A 652 VAL ALA ASP HIS GLY PRO GLY LEU ALA PHE VAL ALA TYR SEQRES 31 A 652 PRO GLU ALA LEU THR LEU LEU PRO ILE SER PRO LEU TRP SEQRES 32 A 652 SER LEU LEU PHE PHE PHE MET LEU ILE LEU LEU GLY LEU SEQRES 33 A 652 GLY THR GLN PHE CYS LEU LEU GLU THR LEU VAL THR ALA SEQRES 34 A 652 ILE VAL ASP GLU VAL GLY ASN GLU TRP ILE LEU GLN LYS SEQRES 35 A 652 LYS THR TYR VAL THR LEU GLY VAL ALA VAL ALA GLY PHE SEQRES 36 A 652 LEU LEU GLY ILE PRO LEU THR SER GLN ALA GLY ILE TYR SEQRES 37 A 652 TRP LEU LEU LEU MET ASP ASN TYR ALA ALA SER PHE SER SEQRES 38 A 652 LEU VAL VAL ILE SER CYS ILE MET CYS VAL ALA ILE MET SEQRES 39 A 652 TYR ILE TYR GLY HIS ARG ASN TYR PHE GLN ASP ILE GLN SEQRES 40 A 652 MET MET LEU GLY PHE PRO PRO PRO LEU PHE PHE GLN ILE SEQRES 41 A 652 CYS TRP ARG PHE VAL SER PRO ALA ILE ILE PHE PHE ILE SEQRES 42 A 652 LEU VAL PHE THR VAL ILE GLN TYR GLN PRO ILE THR TYR SEQRES 43 A 652 ASN HIS TYR GLN TYR PRO GLY TRP ALA VAL ALA ILE GLY SEQRES 44 A 652 PHE LEU MET ALA LEU SER SER VAL LEU CYS ILE PRO LEU SEQRES 45 A 652 TYR ALA MET PHE ARG LEU CYS ARG THR ASP GLY ASP THR SEQRES 46 A 652 LEU LEU GLN ARG LEU LYS ASN ALA THR LYS PRO SER ARG SEQRES 47 A 652 ASP TRP GLY PRO ALA LEU LEU GLU HIS ARG THR GLY ARG SEQRES 48 A 652 TYR ALA PRO THR ILE ALA PRO SER PRO GLU ASP GLY PHE SEQRES 49 A 652 GLU VAL GLN PRO LEU HIS PRO ASP LYS ALA GLN ILE PRO SEQRES 50 A 652 ILE VAL GLY SER ASN GLY SER SER ARG LEU GLN ASP SER SEQRES 51 A 652 ARG ILE HET W5X A 701 26 HETNAM W5X PF-3463275 HETSYN W5X ~{N}-[(3-CHLORANYL-4-FLUORANYL-PHENYL)METHYL]-1-METHYL- HETSYN 2 W5X ~{N}-[[(1~{R},5~{S})-3-METHYL-3- HETSYN 3 W5X AZABICYCLO[3.1.0]HEXAN-6-YL]METHYL]IMIDAZOLE-4- HETSYN 4 W5X CARBOXAMIDE FORMUL 2 W5X C19 H22 CL F N4 O HELIX 1 AA1 ASN A 51 VAL A 64 1 14 HELIX 2 AA2 LEU A 66 ASN A 79 1 14 HELIX 3 AA3 GLY A 81 ALA A 83 5 3 HELIX 4 AA4 PHE A 84 CYS A 95 1 12 HELIX 5 AA5 CYS A 95 SER A 111 1 17 HELIX 6 AA6 LEU A 115 ILE A 120 5 6 HELIX 7 AA7 PHE A 124 SER A 155 1 32 HELIX 8 AA8 SER A 209 TYR A 218 1 10 HELIX 9 AA9 ARG A 233 LEU A 251 1 19 HELIX 10 AB1 VAL A 261 VAL A 281 1 21 HELIX 11 AB2 GLN A 297 ILE A 301 5 5 HELIX 12 AB3 GLU A 303 LEU A 318 1 16 HELIX 13 AB4 GLY A 323 TYR A 331 1 9 HELIX 14 AB5 TYR A 339 GLY A 372 1 34 HELIX 15 AB6 ASP A 374 VAL A 378 5 5 HELIX 16 AB7 GLY A 382 VAL A 388 1 7 HELIX 17 AB8 ALA A 389 THR A 395 1 7 HELIX 18 AB9 ILE A 399 VAL A 434 1 36 HELIX 19 AC1 LYS A 442 GLY A 458 1 17 HELIX 20 AC2 ILE A 459 SER A 463 5 5 HELIX 21 AC3 ALA A 465 ALA A 477 1 13 HELIX 22 AC4 SER A 479 ILE A 496 1 18 HELIX 23 AC5 GLY A 498 GLY A 511 1 14 HELIX 24 AC6 PRO A 515 PHE A 524 1 10 HELIX 25 AC7 PHE A 524 GLN A 540 1 17 HELIX 26 AC8 PRO A 552 LEU A 568 1 17 HELIX 27 AC9 LEU A 568 TYR A 573 1 6 HELIX 28 AD1 ALA A 574 PHE A 576 5 3 HELIX 29 AD2 THR A 585 ASN A 592 1 8 SHEET 1 AA1 2 THR A 545 TYR A 546 0 SHEET 2 AA1 2 TYR A 549 GLN A 550 -1 O TYR A 549 N TYR A 546 SSBOND 1 CYS A 166 CYS A 175 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 TER 4389 PRO A 614 HETATM 4390 C11 W5X A 701 99.542 105.260 104.053 1.00 69.84 C HETATM 4391 C12 W5X A 701 98.733 104.216 105.910 1.00 74.68 C HETATM 4392 C13 W5X A 701 100.814 106.883 106.870 1.00 68.73 C HETATM 4393 C14 W5X A 701 97.526 104.512 104.407 1.00 70.17 C HETATM 4394 C08 W5X A 701 100.616 105.301 104.837 1.00 69.50 C HETATM 4395 C09 W5X A 701 100.247 104.458 106.018 1.00 71.55 C HETATM 4396 C10 W5X A 701 101.218 105.578 106.174 1.00 70.40 C HETATM 4397 C15 W5X A 701 99.229 106.805 108.817 1.00 72.31 C HETATM 4398 C16 W5X A 701 101.499 106.201 109.322 1.00 69.80 C HETATM 4399 C17 W5X A 701 98.600 108.173 108.557 1.00 69.73 C HETATM 4400 C18 W5X A 701 102.980 105.911 109.177 1.00 73.62 C HETATM 4401 C19 W5X A 701 97.113 108.104 108.484 1.00 69.87 C HETATM 4402 C20 W5X A 701 99.334 109.495 108.423 1.00 70.40 C HETATM 4403 C21 W5X A 701 103.536 104.704 108.943 1.00 67.04 C HETATM 4404 C22 W5X A 701 96.327 109.345 108.266 1.00 78.54 C HETATM 4405 C23 W5X A 701 98.556 110.783 108.187 1.00 65.46 C HETATM 4406 C24 W5X A 701 105.077 106.168 109.186 1.00 74.91 C HETATM 4407 C25 W5X A 701 97.035 110.698 108.110 1.00 76.21 C HETATM 4408 C26 W5X A 701 105.850 103.897 108.706 1.00 68.93 C HETATM 4409 F02 W5X A 701 96.316 111.837 107.908 1.00 82.51 F HETATM 4410 N04 W5X A 701 98.331 105.036 105.007 1.00 73.08 N HETATM 4411 N05 W5X A 701 100.562 106.643 108.295 1.00 68.18 N HETATM 4412 N06 W5X A 701 103.914 106.792 109.345 1.00 79.19 N HETATM 4413 N07 W5X A 701 104.824 104.887 108.937 1.00 67.62 N HETATM 4414 O03 W5X A 701 101.068 106.067 110.402 1.00 67.76 O HETATM 4415 CL01 W5X A 701 94.569 109.065 108.193 1.00 98.18 CL CONECT 993 1069 CONECT 1069 993 CONECT 4390 4394 4410 CONECT 4391 4395 4410 CONECT 4392 4396 4411 CONECT 4393 4410 CONECT 4394 4390 4395 4396 CONECT 4395 4391 4394 4396 CONECT 4396 4392 4394 4395 CONECT 4397 4399 4411 CONECT 4398 4400 4411 4414 CONECT 4399 4397 4401 4402 CONECT 4400 4398 4403 4412 CONECT 4401 4399 4404 CONECT 4402 4399 4405 CONECT 4403 4400 4413 CONECT 4404 4401 4407 4415 CONECT 4405 4402 4407 CONECT 4406 4412 4413 CONECT 4407 4404 4405 4409 CONECT 4408 4413 CONECT 4409 4407 CONECT 4410 4390 4391 4393 CONECT 4411 4392 4397 4398 CONECT 4412 4400 4406 CONECT 4413 4403 4406 4408 CONECT 4414 4398 CONECT 4415 4404 MASTER 230 0 1 29 2 0 0 6 4414 1 28 51 END